The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model

Bibliographic Details
Main Authors: Krendyukov, A, Kneisel, N, Zhu, J, Merz, C, Richards, D, Gieffers, C, Van Den Eynde, B
Other Authors: Mitchell, T
Format: Conference item
Language:English
Published: Elsevier 2020
_version_ 1826286842997112832
author Krendyukov, A
Kneisel, N
Zhu, J
Merz, C
Richards, D
Gieffers, C
Van Den Eynde, B
author2 Mitchell, T
author_facet Mitchell, T
Krendyukov, A
Kneisel, N
Zhu, J
Merz, C
Richards, D
Gieffers, C
Van Den Eynde, B
author_sort Krendyukov, A
collection OXFORD
description
first_indexed 2024-03-07T01:49:43Z
format Conference item
id oxford-uuid:99a872a5-16de-42a4-be85-4b7000f9a09f
institution University of Oxford
language English
last_indexed 2024-03-07T01:49:43Z
publishDate 2020
publisher Elsevier
record_format dspace
spelling oxford-uuid:99a872a5-16de-42a4-be85-4b7000f9a09f2022-03-27T00:15:56ZThe role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP modelConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:99a872a5-16de-42a4-be85-4b7000f9a09fEnglishSymplectic ElementsElsevier2020Krendyukov, AKneisel, NZhu, JMerz, CRichards, DGieffers, CVan Den Eynde, BMitchell, T
spellingShingle Krendyukov, A
Kneisel, N
Zhu, J
Merz, C
Richards, D
Gieffers, C
Van Den Eynde, B
The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
title The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
title_full The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
title_fullStr The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
title_full_unstemmed The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
title_short The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
title_sort role of asunercept as a selective cd95l inhibitor in cutaneous melanoma rationale and results from an enhanced tirp model
work_keys_str_mv AT krendyukova theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT kneiseln theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT zhuj theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT merzc theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT richardsd theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT gieffersc theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT vandeneyndeb theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT krendyukova roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT kneiseln roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT zhuj roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT merzc roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT richardsd roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT gieffersc roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel
AT vandeneyndeb roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel